首页> 美国卫生研究院文献>other >Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-involved Diabetic Macular Edema

【2h】

Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-involved Diabetic Macular Edema

机译：理由为糖尿病性视网膜病变临床研究网络治疗协议中心参与的糖尿病性黄斑水肿

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectiveDescribe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema (DME) in a Diabetic Retinopathy Clinical Research Network (DRCR.net) randomized clinical trial.

著录项

期刊名称 other
作者
Lloyd Paul Aiello; Roy W Beck; Neil M. Bressler; David J. Browning; KV Chalam; Matthew Davis; Frederick L Ferris III; Adam Glassman; Raj Maturi; Cynthia R. Stockdale; Trexler Topping;
展开▼
作者单位

展开▼
年(卷),期 -1(118),12
年度 -1
页码 e5–e14
总页数 17
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. New Findings From Diabetic Retinopathy Clinical Research Retina Network Protocol V Confirm a Role for Focal Laser Photocoagulation or Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: New Is Not Always Best [J] . Peto Tunde, Chakravarthy Usha JAMA ophthalmology . 2019,第7期

机译：糖尿病视网膜病变临床研究的新发现视网膜网络协议v确认了局灶性激光光凝或观察中枢神经糖尿病黄斑水肿和良好的视力的作用：新的并不总是最好的
2. What is the best anti-vascular endothelial growth factor agent for the treatment of diabetic macular edema? Review of the 2-year results of Diabetic Retinopathy Clinical Research Network Protocol T [J] . Michal Schaap-Fogler, Rita Ehrlich 眼科学报（英文版） . 2016,第004期

机译：什么是治疗糖尿病性黄斑水肿的最佳抗血管内皮生长因子药物？糖尿病视网膜病变临床研究网络协议T的2年结果回顾
3. Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial [J] . Ross Eric L., Hutton David W., Stein Joshua D., JAMA ophthalmology . 2016,第8期

机译：从糖尿病性视网膜病变临床研究网络比较有效性试验中，Aflibercept，Bevacizumab和Ranibizumab用于糖尿病性黄斑水肿治疗的成本效益分析
4. Microaneurysm Turnover and Phenotypes of Nonproliferative Diabetic Retinopathy Progression to Clinically Significant Macular Edema [C] . Cunha-Vaz J International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：微生物肌瘤周转和非糖尿病视网膜病变进展到临床显着性黄斑水肿的表型
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Green or Yellow Laser Treatment for Diabetic Macular Edema: ExploratoryAssessment within the Diabetic Retinopathy Clinical Research Network [O] . Susan B. Bressler, Talat Almukhtar, Lloyd Paul Aiello, -1

机译：绿色或黄色激光治疗糖尿病性黄斑水肿：探索性糖尿病视网膜病变临床研究网络中的评估
7. Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-Involved Diabetic Macular Edema [O] . Joslin Diabetes Center, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts ( host institution ), Aiello, Lloyd Paul, Beck, Roy W., 2011

机译：中心性糖尿病性黄斑水肿的糖尿病性视网膜病变临床研究网络治疗方案的基本原理

Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-involved Diabetic Macular Edema

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅